Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1.
about
Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteinsA double-edged sword: does highly active antiretroviral therapy contribute to syphilis incidence by impairing immunity to Treponema pallidum?The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?Lipoprotein-dependent and -independent immune responses to spirochetal infection.Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection.A Case of Ocular Syphilis in a 36-Year-Old HIV-Positive Male.The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men.Biological basis for syphilis.Progress towards an effective syphilis vaccine: the past, present and future.A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectinThe effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semenThe role of sexually transmitted diseases in HIV transmission.Evaluation of macrolide resistance and enhanced molecular typing of Treponema pallidum in patients with syphilis in Taiwan: a prospective multicenter study.Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis.Similarities in the Markers of Inflammation Between Men With Syphilis and Women With Increased Risk of HIV Acquisition.HIV Incidence Among Men Who Have Sex With Men After Diagnosis With Sexually Transmitted Infections.Syphilis negatively influences the response to hepatitis C virus treatment in an HIV-infected patient.Point-of-Care Sexually Transmitted Infection Diagnostics: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting.The Cross-Talk between Spirochetal Lipoproteins and Immunity.Management of severe non-TB bacterial infection in HIV-infected adults.Production of proinflammatory cytokines in the human THP-1 monocyte cell line following induction by Tp0751, a recombinant protein of Treponema pallidum.Clinical and epidemiological characteristics of patients with early syphilis from three academic centres in Poland, Germany and Ireland: initial findings from the POETS study.[Syphilis with HIV coinfection].
P2860
Q24681145-4F65422C-F3D8-4070-8DAB-9DE92CA8E9B3Q30238982-6E3A77BA-7985-4582-87FC-435071423D0BQ33662836-7F9695E5-CAA4-4E4F-B019-0B0A54D51071Q33910726-6E6FBEA4-31A5-4DAB-A020-621621FE6B74Q34005053-98705D84-E79C-48A1-9DDE-C9ADE28BA10DQ34087352-CAD442BD-DBB7-434F-9F02-82A0B43091ACQ34142034-8D217245-5A0F-4916-B641-803FF5DEE745Q34334047-3BC92815-D55B-4F41-8A40-70A275B0961FQ34490385-2432F9A0-3428-4F06-ACF2-F0F5FAFC9C97Q34589271-441508A5-EEF9-4D5D-942D-15A71A45C078Q35531976-272AFD95-B8C8-4B89-A54F-0818DE7798D7Q35701598-AA833779-FDF6-4F4D-8B8C-973D5DC25DCAQ36118760-DD95B69D-5F14-4413-9E9B-EE17324B5E81Q36253541-57F3B488-22FB-4E59-AE0D-ADF0C2007F59Q36515902-B1542EB9-3611-463C-B76B-F6F488465104Q36682112-E4C21DB8-921A-443F-B1C5-3C2439FC1C5DQ37701225-76B49986-D01F-4569-BA33-4D683641D82AQ37834747-A6B8EF1A-4938-4341-8902-5E782D0E8B29Q38234946-95BAE2C0-C9E0-46DC-B5B8-F695F3E776AFQ38314390-B9B207DD-B4E7-42BF-991D-E75BFEFA1F54Q39685707-E23527CD-8195-40E4-83DA-A92F691C3DBCQ41288747-3951F2DE-86CC-4181-B57F-49DD5898CC25Q46799286-1FF021E4-E226-4B3A-82E7-EB7CBA0FD624
P2860
Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@en
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@nl
type
label
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@en
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@nl
prefLabel
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@en
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@nl
P2093
P356
P1476
Virulent Treponema pallidum, l ...... immunodeficiency virus type 1.
@en
P2093
D A Wilkinson
J D Radolf
J S Sheffield
M V Norgard
T J Sellati
P304
P356
10.1086/315209
P407
P577
2000-01-01T00:00:00Z